Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/684,759external-prioritypatent/US4935495A/en
Priority claimed from US06/776,321external-prioritypatent/US4906562A/en
Application filed by OncogenfiledCriticalOncogen
Publication of FI923418A0publicationCriticalpatent/FI923418A0/en
Publication of FI923418ApublicationCriticalpatent/FI923418A/en
Publication of FI94291BpublicationCriticalpatent/FI94291B/en
Application grantedgrantedCritical
Publication of FI94291CpublicationCriticalpatent/FI94291C/en
Preparation Of Compounds By Using Micro-Organisms
(AREA)
Abstract
The invention concerns new monoclonal antibodies that identify glycolipid antigens associated with human non small-cell lung carcinoma (NSCLC) and with other specific human carcinomas. The antibodies bind to normal human cells to a much lesser degree than to tumor cells. The antibodies can be used in diagnostic methods, like detection of malignant cells associated with NSCLC.
Antibodies and antigens useful in the diagnosis and treatment of cancer,methods for the production thereof and methods for testing for the presence of cancer cells using the same